DLDimitra‐Aikaterini Lintzeri

Dimitra‐Aikaterini Lintzeri

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Dimitra‐Aikaterini Lintzeri has a total of 6 co-authors. Here are the top co-authors by number of shared publications:

  • Doris Wilborn

    Klinik für Dermatologie Venerologie und Allergologie Charité – Universitätsmedizin Berlin Corporate Member of Freie Universität Berlin Humboldt‐Universität zu Berlin und Berlin Institute of Health Berlin Deutschland

    1 shared publication
  • Jan Kottner

    Charité-Universitätsmedizin, Berlin, Germany

    1 shared publication
  • N. Karimian

    Department of Dermatology, Venerology and Allergology Clinical Research Center for Hair and Skin Science Charité‐Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin Berlin Germany

    1 shared publication
  • Rashmi Singh

    Department of Dermatology, Venereology, and Allergology Charité‐Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt‐Universität zu Berlin Berlin Germany

    1 shared publication
  • U. Blume‐Peytavi

    Department of Dermatology, Venerology and Allergology Clinical Research Center for Hair and Skin Science Charité‐Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin Berlin Germany

    1 shared publication
  • Ulrike Blume-Peytavi

    Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Dermatology, Venereology and Allergology, Clinical Research Center for Hair and Skin Science , Berlin

    1 shared publication

Latest Publications

  • Open Access

    Health‐related quality of life (hrQoL) among patients with primary cicatricial alopecia (PCA): A systematic review

    by Rashmi Singh, Doris Wilborn, Dimitra‐Aikaterini Lintzeri, Ulrike Blume‐Peytavi

    Cicatricial alopecia may lead to an enormous emotional burden, social distress, and psychological impairment affecting the quality of life. The objective of this review is to systematically describe the health‐related quality of life in adults with primary cicatricial alopecia and its subtypes. Studies that (i) reported quality of life in patients with primary cicatricial alopecia or its subtypes; (ii) were original research and not a conference abstract or review (iii) with patients >18 years of age were included in the review. The studies not mentioning quality of life specifically for the cicatricial alopecia cohort were excluded. We searched for literature via OVID in Medline and Embase, in Web of Science, CINAHL, EBSCO (APA PsycArticles, APA PsycInfo, and PSYNDEX Literature), in the Cochrane Library and for grey literature from its inception date till 12 November 2022. The risk of bias was assessed by using the AXIS tool for cross‐sectional studies by two independent authors. Thirteen observational cross‐sectional and one single‐arm study, including 572 patients and eight different instruments, fulfilled the inclusion criteria. Results are descriptively synthesized, and associated factors of quality of life are presented. The data from studies that used the Dermatology Life Quality Index tool (DLQI) showed that more than 70% of the patients have an impaired life quality. While trichodynia and anxiety have a negative effect on the quality of life, disease duration, education, employment, and marital status have no effect. The findings were inconsistent for other factors. Most of these studies failed to justify the sample size. Furthermore, the risk of bias assessment could not surely rule out a non‐response bias. Our results suggest that cicatricial alopecia treatments must be integrated with psychosocial intervention and indicate the need for further research with homogenous and more comprehensive tools to identify and address this patient population's unmet mental health needs.


  • Top Cited Papers
    Open Access

    Epidermal thickness in healthy humans: a systematic review and meta‐analysis

    by D.A. Lintzeri, N. Karimian, U. Blume‐Peytavi, J. Kottner

    Several skin diseases are characterized by epidermal alterations affecting epidermal thickness. Reference values of epidermal thickness in healthy humans and knowledge of possible differences regarding age, sex, skin phototype, and ethnic origin are essential in research and in clinical practice. The objectives of this systematic review were to provide epidermal thickness reference values for healthy human skin and describe possible effects of measurement methods, age, sex, ethnic origin, and skin phototype. A combined search in the databases Medline and Embase, and other sources were conducted. Searches covered a period from 1946 to 3 June 2020. Included studies were primarily observational and interventional studies providing means and spread values of epidermal thickness estimates in healthy humans, with clear reporting of skin area, age, and measurement method, and optional reporting of sex, ethnic origin, and skin phototype. Data were extracted per skin area and pooled in random‐effects models. A total of 142 studies were included in the qualitative synthesis and 133 in the meta‐analysis. Pooled epidermal thickness estimates were calculated for 37 skin areas. The lowest epidermal thickness of 31.2 (95% CI 27.8–34.6) μm was reported for the penis and the highest of 596.6 (95% CI 443.9–749.3) μm for the plantar aspect of the foot. Differences in epidermal thickness estimates obtained by histology, optical coherence tomography, and laser scanning microscopy were minor. High‐frequency ultrasonography produces systematically higher values. The epidermis was thinner in aged skin. Differences between sexes and among ethnic origins were minor. Epidermal thickness reference values are provided for 37 skin areas. In conclusion, the epidermis tends to become thinner by ageing and does not seem to be influenced by sex. Histology, optical coherence tomography, and laser scanning microscopy might be used interchangeably to measure epidermal thickness, whereas high‐frequency ultrasound should not be used.